Components of equity [axis] Issued capital [member] Contributed surplus [member] Retained earnings [member] Accumulated other comprehensive income [member] Counterparties [axis] Pharmanovia [member] NK Meditech Limited [member] Davimed GmbH [Member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Classes of property, plant and equipment [axis] Equipment Not Available For Use [Member] Equipments [Member] Office equipment [member] Buildings [member] Leasehold improvements [member] Accumulated depreciation [member] Characteristics of defined benefit plans [axis] Pension defined benefit plans [member] Other benefit plans [member] Types of antidilutive instruments [axis] Warrants [member] Creation date [axis] June 2024 [member] Stock options and DSUs [Member] Major customers [axis] One customer [member] Continuing and discontinued operations [axis] Discontinued operations [member] Range [axis] Bottom of range [member] Top of range [member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of financial position [abstract] ASSETS Current assets Cash and cash equivalents Trade and other receivables Inventories (note 4) Prepaid expenses and other assets (note 5) Assets held for sale Total current assets Non-current assets Restricted cash and cash equivalents Deposits Property and equipment (note 6) Intangible assets Total non-current assets Total assets LIABILITIES Current liabilities Accounts payable and accrued liabilities (note 7) Provisions Income taxes payable Current portion of lease liabilities Warrant liability (note 9) Total current liabilities Non-current liabilities Deferred revenues (note 3) Lease liabilities Employee future benefits (note 8) Total non-current liabilities Total liabilities Shareholders’ equity Share capital (note 10) Contributed surplus Retained earnings (accumulated deficit) Accumulated other comprehensive loss Total shareholders’ equity Total liabilities and shareholders’ equity Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance Net profit (loss) Foreign currency translation adjustments Actuarial gain on defined benefit plan Comprehensive profit (loss) Share-based compensation costs Exercise of warrants Ending balance Profit or loss [abstract] Continuing operations Revenues (note 3) Cost of sales Gross profit Research and development Selling, general and administrative Total operating expenses Loss from continuing operations Foreign exchange gain (loss) Finance costs Interest income Other income Change in fair value of warrant and DSU liabilities Other income (loss) Loss before income taxes from continuing operations Income tax recovery (expense) Net loss from continuing operations Discontinued operations Income (loss) from discontinued operations, net of tax (note 14) Net income (loss) Other comprehensive income (loss): Items that may be reclassified subsequently to profit or loss: Items that will not be reclassified subsequently to profit or loss: Actuarial gain (loss) on defined benefit plans (note 8) Comprehensive income (loss) Basic loss per share from continuing operations Diluted loss per share from continuing operations Basic income (loss) per share (note 12) Diluted income (loss) per share (note 12) Weighted average number of shares outstanding (basic) Weighted average number of shares outstanding (diluted) Statement of cash flows [abstract] Cash flows from operating activities Net income (loss) for the period Items not affecting cash and cash equivalents: Deconsolidation of German subsidiaries (note 14) Depreciation and amortization Share-based compensation costs Loss on disposal of property and equipment Employee future benefits Amortization of deferred revenues Change in fair value of warrant and DSU liabilities Other non-cash items Changes in operating assets and liabilities (note 11) Net cash used in operating activities Cash flows from financing activities Payments on lease liabilities Net cash used in financing activities Cash flows from investing activities Deconsolidation of German subsidiaries (note 14) Purchase of property and equipment Proceeds on disposal of property and equipment Changes in restricted cash equivalents Net cash used in investing activities Effect of exchange rate changes on cash and cash equivalents Net change in cash and cash equivalents Cash and cash equivalents – Beginning of period Cash and cash equivalents – End of period Notes and other explanatory information [abstract] Business overview Basis of presentation Revenue Inventories Prepaid expenses and other assets Property and equipment Accounts payable and accrued liabilities Employee future benefits Warrants Warrants Shareholders’ equity Supplemental disclosure of cash flow information Net income (loss) per share Segment information Discontinued operations Commitments and Contingencies Discontinued operations Loss of control New standards and amendments Critical accounting estimates and judgements Summary of deferred revenue Schedule of inventories Summary of prepaid expenses and other current assets Schedule of property and equipment Summary of detailed information about accounts payable and accrued liabilities Summary of net defined benefit liability asset Summary of warrants activity reclassified equity Schedule of warrants outstanding Summary of share capital Summary of number and weighted average exercise prices of options Summary of changes in operating assets and liabilities Summary of pertinent data relating to computation of basic and diluted net loss per share Schedule of discontinued assets and liabilities Schedule of discontinued profit or loss Schedule of discontinued cash flows Net loss from continuing operations Cash flow from operating activities Accumulated deficit Tariff percentage Exemption percentage Disclosure of offsetting of financial assets [table] Current Non-Current Total Raw materials Work in progress Finished goods Inventories Revenue from related party Prepaid insurance Prepaid research and development Other Total Disclosure of reconciliation of changes in goodwill [table] Property and equipment, Beginning Amounts derecognized due to discontinued operations Additions Impairment Disposals Commissioning of assets Impact of foreign exchange rate changes Property and equipment, Ending Amounts derecognized due to deconsolidation of German subsidiaries Amortization Inventories expensed to cost of goods sold Trade accounts payable Accrued research and development costs Accrued employee benefits Payroll tax and other statutory liabilities Other accrued liabilities Payables and accrued liabilities Disclosure of defined benefit plans [table] Change in plan liabilities Balances – Beginning of the period Current service cost Interest cost Actuarial loss (gain) from changes in financial assumptions Benefits paid Impact of foreign exchange rate changes Deconsolidation of German subsidiaries Balances – End of the period Change in plan assets Balances – Beginning of the period Interest income from plan assets Employer contributions Employee contributions Benefits paid Remeasurement of plan assets Unrecognized Asset due to Asset Ceiling Impact of foreign exchange rate changes Deconsolidation of German subsidiaries Balances – End of the period Net liability of the unfunded plans Net liability of the funded plans Net amount recognized as Employee future benefits Amounts recognized: In net loss Actuarial gain (loss) on defined benefit plans in other comprehensive loss Depreciated assets Right-of-use, net carrying amount of property and equipment Impairment description Summary Of Warrants Activity Reclassified Equity Warrants outstanding, beginning of year Weighted average exercise price, beginning of year Warrants outstanding, beginning of year, value Warrants, exercised Weighted average exercise price, exercised Warrants outstanding, exercised, value Warrants, expired Weighted average exercise price,expired Warrants outstanding, expired, value Change in fair value of warrants Weighted average exercise price, Change in fair value of warrants Change in fair value of warrants, value Warrants outstanding, ending of year Weighted average exercise price, ending of year Warrants outstanding, ending of year, value Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] Warrant outstanding, Number (in shares) Warrant outstanding, Weighted average remaining contractual life (years) Warrant outstanding, Weighted average exercise price Beginning balance, shares Granted, shares Granted, amount Ending balance, shares Number of stock options, beginning Weighted average exercise price, beginning Number of stock options, cancelled/forfeited Weighted average exercise price, cancelled/forfeited Number of stock options, ending Weighted average exercise price, ending Trade and other receivables Inventory Prepaid expenses and other current assets Accounts payable and accrued liabilities Deferred revenues Provision for restructuring and other costs Employee future benefits Increase (decrease) in operating assets and liabilities Net loss from continuing operations Net income (loss) Weighted-average shares outstanding (basic) Weighted-average shares outstanding (diluted) Basic income (loss) per share Diluted income (loss) per share Items excluded from the calculation of diluted net loss per share due to their anti-dilutive effect: Anti-dilutive shares Compensation expenses Disclosure of major customers [table] Revenue percentage Trade and other receivables percentage Disclosure of analysis of single amount of discontinued operations [table] Inventories Prepaid expenses and other assets Accounts payable and accrued liabilities Provisions Income taxes payable Current portion of lease liabilities Total current liabilities Deferred revenues (note 3) Lease liabilities Employee future benefits (note 8) Total non-current liabilities Total liabilities Carrying amount of net liabilities deconsolidated Carrying amount of net liabilities deconsolidated Gain on deconsolidation Revenues Research and development Selling, general and administrative Total operating expenses Gain on deconsolidation Income (loss) from discontinued operations, net of tax Net cash used in operating activities Net cash used in financing activities Net cash provided by investing activities Net change in cash and cash equivalents (Loss) / profit from discontinued operation Disclosure of detailed information about borrowings [table] Annual royalty percentage Disclosure of property plant and equipments explanatory. Equipment Not Available For Use [Member] Equipments [Member] Impairment of property and equipment. Amounts derecognized due to discontinued operations property plant and equipment. Accumulated depreciation [member] Amortization. Deposits non current. Amounts derecognized due to deconsolidation of German subsidiaries property plant and equipment. Depreciated assets. Contributed surplus [member] Impairment description. Disclosure of detailed information about payables and accrued liabilities explanatory. Accrued research and development costs. Accrued payroll tax and other statutory liabilities. Other benefit plans [member] Current service cost (residual value). Other income (expenses). Change in fair value of warrant and DSU liabilities. Interest income from plan assets. Assets employer contributions. Assets Employee contributions. Increase (decrease) in net asset available for benefit. Remeasurement of plan assets. Unrecognized asset due to asset ceiling. Impact of foreign exchange rate changes assets of benefit plan. Deconsolidation of German subsidiaries assets. Net liability of the unfunded plans. Net liability of the funded plans. Net amount recognized as Employee future benefits. Postemployment benefit expense defined benefit plans. Disclosure warrants explanatory. Disclosure of warrants activity reclassified into equity. Class of warrant or right outstanding 1. Class of warrant or right outstanding weighted average exercise price of warrants or rights. Warrants and right outstanding. Class of warrant or rights exercised. Class of warrant or right exercised weighted average exercise price of warrants or rights. Warrants and right exercised. Warrants and right expired. Change in fair value of warrants value. Change in fair value of warrants weighted average exercise price of warrants or rights. Class of warrant or right exercised weighted average expired price of warrants or rights. Change in fair value of warrants. Class of warrant or rights expired. Disclosure of range of exercise prices of outstanding share warrants. June 2024 [member] Weighted average remaining contractual life of outstanding share warrant2019 Number if shares granted value. Compensation expenses. Disclosure of changes in operating assets and liabilities table text block. Adjustments for decrease increase in current prepayments and other current assets Adjustments for increase decrease in provisions. One customer [member] Percentage of trade and other receivables. Annual royalty percentage. Disclosure of assets and liabilities of disposal group classified as held for sale and discontinued operations explanatory. Deconsolidation of German subsidiaries. Adjustments for employee future benefits. Adjustments for amortization of deferred income. Change in fair value of warrant and DSU liabilities. Proceeds from deconsolidation of German subsidiaries. Percentage of tariffs issued. Percentage of exemption rate. Description of accounting policy for land of control explanatory. Disclosure of statement of profit or loss from discontinued operations explanatory. Disclosure of detailed information about deferred revenue explanatory. Pharmanovia [member] NK Meditech Limited [member] Davimed GmbH [Member] Disclosure of cash flows from discontinued operations explanatory. Disclosure of inventory explanatory. Inventories expensed to cost of goods sold. Disclosure of prepaid expenses and other current assets explanatory. Prepaid research and development. Stock options and DSUs [Member] Current assets [Default Label] Non-current assets [Default Label] Assets Current liabilities [Default Label] Non-current liabilities [Default Label] Liabilities Equity attributable to owners of parent Equity and liabilities Cost of sales Gross profit Operating expense Profit (loss) from operating activities Finance costs Finance income (cost) Profit (loss) before tax Tax expense (income) DeconsolidationOfGermanSubsidiaries Adjustments for share-based payments IncreaseDecreaseInFairValueOfWarrantAndDSULiabilities Increase (decrease) in working capital Payments of lease liabilities, classified as financing activities ProceedsFromDeconsolidationOfGermanSubsidiaries Purchase of property, plant and equipment, classified as investing activities Disclosure of employee benefits [text block] DisclosureWarrantsExplanatory Disclosure of share capital, reserves and other equity interest [text block] Disclosure of discontinued operations [text block] Description of accounting policy for discontinued operations [text block] AmountsDerecognizedDueToDiscontinuedOperationsPropertyPlantAndEquipment ImpairmentLossRecognisedInProfitOrLossPropertyAndEquipment Disposals, property, plant and equipment AmountsDerecognizedDueToDeconsolidationOfGermanSubsidiariesPropertyPlantAndEquipment Net defined benefit liability (asset) Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions Decrease (increase) in net defined benefit liability (asset) resulting from payments in respect of settlements Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset) Assets of benefit plan IncreaseDecreaseInNetAssetAvailableForBenefit Remeasurement of plan assets UnrecognizedAssetDueToAssetCeiling Impact of foreign exchange rate changes [Default Label] DeconsolidationOfGermanSubsidiariesAssets WarrantsAndRightOutstanding ClassOfWarrantOrRightsExercised ClassOfWarrantOrRightsExpired Number of shares issued Number of share options outstanding in share-based payment arrangement Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options forfeited in share-based payment arrangement Adjustments for decrease (increase) in trade and other receivables Adjustments for increase (decrease) in trade and other payables Adjustments for increase (decrease) in employee benefit liabilities Non-current provisions Reclassification adjustments on exchange differences on translation of foreign operations, before tax